Sign in

    Church & Dwight Co Inc (CHD)

    You might also like

    Church & Dwight Co., Inc. develops, manufactures, and markets a wide array of consumer household, personal care, and specialty products. The company is known for its well-recognized brands such as ARM & HAMMER® baking soda products, OXICLEAN® cleaning solutions, VITAFUSION® and L’IL CRITTERS® gummy dietary supplements, BATISTE® dry shampoo, and WATERPIK® water flossers and showerheads . Operating in three segments—Consumer Domestic, Consumer International, and Specialty Products Division (SPD)—the company focuses on delivering quality products across various categories . Seven of their brands, including ARM & HAMMER® and OXICLEAN®, are designated as "power brands" and significantly contribute to their net sales and profits .

    1. Consumer Domestic - Develops and markets a broad range of household and personal care products within the United States, contributing significantly to the company's net sales.
    2. Consumer International - Offers consumer products similar to the domestic segment but focuses on international markets, expanding the company's global reach.
    3. Specialty Products Division (SPD) - Provides specialty products that cater to niche markets, representing a smaller portion of the company's overall sales.
    NamePositionStart DateShort Bio
    Barry A. BrunoExecutive Vice President, Chief Marketing Officer, and President – Consumer DomesticApril 2022Barry A. Bruno has been serving in his current role since April 2022. He previously served as Executive Vice President and Chief Marketing Officer from October 2021 to April 2022, and Executive Vice President, International from January 2021 to September 2021. He joined CHD in 2013 and held various positions at Johnson & Johnson before that .
    Brian BuchertExecutive Vice President of Strategy, M&A and Business PartnershipsApril 2022Brian Buchert has been in his current role since April 2022. He was previously Vice President of Corporate Strategy and M&A from January 2016 to March 2022. He has been with CHD since 2006 and played a key role in acquiring 18 brands with a total transaction value exceeding $5.3 billion .
    Patrick D. de MaynadierExecutive Vice President, General Counsel, and SecretaryDecember 2011Patrick D. de Maynadier has been serving as Executive Vice President, General Counsel, and Secretary since December 2011. Before joining CHD, he held various roles at Hill-Rom Holdings, Inc. and was a corporate and securities partner at Bracewell & Patterson, L.L.P. .
    Richard A. DierkerExecutive Vice President, Chief Financial Officer, and Head of Business OperationsApril 2022Richard A. Dierker has been in his current role since April 2022. He previously served as Executive Vice President and Chief Financial Officer from January 2016 to April 2022. He joined CHD in 2009 and held various financial roles before that .
    Matthew T. FarrellPresident and Chief Executive OfficerJanuary 2016Matthew T. Farrell has been the President and CEO since January 2016 and Chairman of the Board since May 2019. He previously served as Executive Vice President, Chief Operating Officer, and Chief Financial Officer from November 2014 to December 2015 .
    Rene M. HemseyExecutive Vice President, Chief Human Resources OfficerApril 2022Rene M. Hemsey has been serving in her current role since April 2022. She was previously Executive Vice President, Global Human Resources from February 2020 to March 2022 and has been with CHD since August 2001 .
    Carlen HookerExecutive Vice President, Chief Commercial OfficerApril 2023Carlen Hooker has been in her current role since April 2023. She was previously Vice President, Mass Channel from September 2019 to April 2023. Before joining CHD, she held various positions at companies such as Ferrero U.S.A. Inc., Acosta, and others .
    Carlos G. LinaresExecutive Vice President, Chief Technology Officer & Global New Product InnovationApril 2022Carlos G. Linares has been serving in his current role since April 2022. He was previously Executive Vice President, Global Research & Development from June 2017 to April 2022. He has extensive experience in R&D product development and innovation .
    Joseph J. LongoVice President, Controller, and Chief Accounting OfficerSeptember 2020Joseph J. Longo has been in his current role since September 2020. Before joining CHD, he held positions at Dorman Products Inc., Pinnacle Foods Inc., and Tyco International Ltd. .
    Michael G. ReadExecutive Vice President, President Consumer International & Specialty Products DivisionOctober 2021Michael G. Read has been serving in his current role since October 2021. He joined CHD in 2016 and previously worked at Aryzta AG and Molson Coors .
    Rick SpannExecutive Vice President, Chief Supply Chain OfficerApril 2022Rick Spann has been in his current role since April 2022. He was previously Executive Vice President, Global Operations from May 2017 to April 2022. Before joining CHD, he had a long career at Colgate-Palmolive Company .
    Richard DierkerUpcoming President and Chief Executive OfficerMarch 31, 2025Richard Dierker is set to become the President and CEO on March 31, 2025. He has been with CHD for 15 years, serving in various roles, including Executive Vice President, Chief Financial Officer, and Head of Business Operations since April 2022 .
    1. With the deceleration in growth of key brands like THERABREATH and HERO, despite their strong performance, how do you plan to maintain double-digit growth rates as the law of large numbers takes effect and category growth rates change?

    2. Given the slowdown in underlying category growth and the pressure on organic growth guidance, does your outlook assume further deceleration, and how do you plan to balance price/mix and volumes in this context?

    3. In light of rising commodity costs affecting gross margins, such as increases in pulp, paper, HDPE, and ethylene, what strategies are you implementing to mitigate these pressures and prevent further margin deceleration in the second half?

    4. Considering your disadvantage in the vitamins market due to a less extensive sugar-free portfolio compared to competitors, how are you planning to renovate your product offerings to address shifting consumer preferences towards sugar-free options?

    5. With the departure of key executive Barry, who has been integral to your success, how do you plan to ensure continuity in leadership and strategy, and what is your timeline for filling this critical role?

    Program DetailsProgram 1
    Approval DateOctober 28, 2021
    End Date/DurationNo expiration date
    Total additional amount$1,000.0 million
    Remaining authorization$658.9 million
    DetailsReplaced the 2017 program; aims to manage capital structure and return value to shareholders
    YearAmount Due (in millions)Debt TypeInterest Rate (%)% of Total Debt
    20243.4Various debt due to international banks N/A0.2% = (3.4 / 2,211.6) * 100
    2027425.03.15% Senior Notes 3.15 19.2% = (425.0 / 2,211.6) * 100
    2031400.02.3% Senior Notes 2.3 18.1% = (400.0 / 2,211.6) * 100
    2032500.05.6% Senior Notes 5.6 22.6% = (500.0 / 2,211.6) * 100
    2047400.03.95% Senior Notes 3.95 18.1% = (400.0 / 2,211.6) * 100
    2052500.05.00% Senior Notes 5.00 22.6% = (500.0 / 2,211.6) * 100

    Competitors mentioned in the company's latest 10K filing.

    • P&G
    • The Clorox Company
    • Colgate-Palmolive Company
    • S.C. Johnson & Son, Inc.
    • Nestle Purina PetCare Company
    • Nestle Health Science
    • Haleon plc
    • Henkel
    • Reckitt Benckiser Group plc
    • Kenvue Inc.
    • Pfizer Inc.
    • Bayer AG
    • NBTY, Inc.
    • Koninklijke Philips N.V.
    • Unilever PLC
    • Sanofi
    • Pharmavite LLC
    • Edgewell Personal Care
    • Cargill Incorporated (competitor in the specialty chemicals product line)
    • Lallemand Inc. (competitor in the specialty chemicals product line)
    • Solvay Chemicals, Inc. (competitor in the specialty chemicals product line)
    • Genesis Alkali (competitor in the specialty chemicals product line)
    • Natural Soda, Inc. (competitor in the specialty chemicals product line)
    NameStart DateEnd DateReason for Change
    Deloitte & Touche LLP1968 PresentCurrent auditor

    Recent developments and announcements about CHD.

    Financial Reporting

      Earnings Report

      ·
      5 days ago

      Church & Dwight Co., Inc. (CHD) has released its fourth quarter and full year 2024 earnings results, reporting that net sales, EPS, and cash from operations exceeded their outlook. For the fourth quarter, net sales grew by 3.5% with domestic sales increasing by 2.7% and international sales by 10.2%. The Specialty Products Division saw a decline of 6.6%. Organic sales increased by 4.2% overall, with a 9.6% increase internationally and a 10.3% increase in the Specialty Products Division.

      For the full year 2024, net sales increased by 4.1% to $6,107.1 million, surpassing the company's outlook of approximately 3.5% growth. Organic sales grew by 4.6%, driven by a 3.3% increase in volume and a 1.3% positive pricing and mix. The company reported a full year adjusted EPS of $3.44, an 8.5% increase compared to 2023.

      Looking ahead to 2025, Church & Dwight expects net sales growth of 3 to 4% and adjusted EPS growth of 7 to 8%. The company also announced a 4% increase in its dividend.

      Significant trends affecting financial performance include strong consumer demand across its portfolio, successful new product launches, and increased global online sales, which accounted for 21.4% of total consumer sales in 2024. The company also achieved margin expansion and efficient working capital management, resulting in strong cash flow generation of over $1.1 billion from operations in 2024.